Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Plus Therapeutics Inc (PSTV)

Plus Therapeutics Inc (PSTV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,263
  • Shares Outstanding, K 22,198
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,400 K
  • 60-Month Beta 0.41
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.75
Trade PSTV with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.99
  • Most Recent Earnings -0.19 on 04/21/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +28.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4102 +29.30%
on 05/12/22
0.9400 -43.57%
on 04/21/22
-0.3416 (-39.17%)
since 04/20/22
3-Month
0.4102 +29.30%
on 05/12/22
1.1400 -53.47%
on 03/01/22
-0.4896 (-48.00%)
since 02/18/22
52-Week
0.4102 +29.30%
on 05/12/22
2.9500 -82.02%
on 06/11/21
-1.7196 (-76.43%)
since 05/20/21

Most Recent Stories

More News
Plus Therapeutics to Present Virtually at the 2022 HC Wainwright Global Investment Conference

AUSTIN, Texas, May 18, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing innovative,...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics to Present at the 2022 Q2 Investor Summit

AUSTIN, Texas, April 26, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing innovative,...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights

First patient dosed in ReSPECT-LM Phase 1/2a dose escalation trial of 186RNL for leptomeningeal metastases Closed in-licensing...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics Announces Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting

AUSTIN, Texas, April 19, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics to Announce First Quarter 2022 Financial Results and Host Conference Call on April 21, 2022

AUSTIN, Texas, April 14, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting

AUSTIN, Texas, April 08, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics and Medidata Announce Expanded Clinical Trial Partnership

Companies collaborate to design innovative registrational trial of 186RNL for recurrent glioblastoma Proprietary Synthetic Control ArmⓇ solution intended...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics Announces Upcoming Participation at the 2022 SNMMI Therapeutics Conference

AUSTIN, Texas, March 03, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a U.S. clinical-stage pharmaceutical company...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics Partners with Medidata to Apply Innovative Synthetic Control ArmⓇ Solution to Accelerate Brain Cancer Clinical Trial

Initial plan to evaluate project feasibility, may lead to expanded partnership for clinical and regulatory implementation...

PSTV : 0.5304 (+4.53%)
Plus Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 24, 2022

AUSTIN, Texas, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company...

PSTV : 0.5304 (+4.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics...

See More

Key Turning Points

3rd Resistance Point 0.6691
2nd Resistance Point 0.6292
1st Resistance Point 0.5798
Last Price 0.5304
1st Support Level 0.4905
2nd Support Level 0.4506
3rd Support Level 0.4012

See More

52-Week High 2.9500
Fibonacci 61.8% 1.9798
Fibonacci 50% 1.6801
Fibonacci 38.2% 1.3804
Last Price 0.5304
52-Week Low 0.4102

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar